Redeye provides an initial take on Alligator’s Q2 report.
I dag offentliggjorde GHP sin delårsrapport för det andra kvartalet 2021.
Verkkokauppa.com reports Q2 results on Fri, Jul 16.
The Q2 results showed sales and earnings clearly below SEB expectations (no cons) with the COVID-19 pandemic continuing to hamper performanc...
Next Games has made progress during H1, with two new games in soft launch, and we expect those games...
With the completed sale of the Danish activities to Spar Nord, we expect BankNordik to again focus o...
Redeye maintains its positive view and valuation of Orexo at a base case of SEK 80 per share.
Q2’21 expectations We expect Q2 sales of SEK 43m, up 42% y-o-y (29% from development and solutions a...
Odramatisk rapport Utvecklingen under Q2 2021 visade på hög aktivitet inom affärsområdet drug develo...
Q1 expectations Lagercrantz should have a solid Q1’21/22.
Redeye leaves a comment on CLS following today's update regarding its new sterilization supplier and...
Redeye views the first commercial order from Germany as intriguing.
Patentansökan för KebNis första egenutvecklade inertial sensing-applikation öppnar dörren för en helt ny vertikal med långsiktig potential i...
Finnair reports Q2 results on Jul 15. Capacity is being scaled up while passenger numbers have botto...
During the first half of 2020, M&A activity in the metals and mining industry declined drastically.
Redeye bedömer att sannolikheten för godkännande av lecanemab har ökat från 55% till 63% och justerar samtidigt priset på lecanemab.
Idag, 2021-07-09, meddelade Neodynamics att den första beställningen på ett NeoNavia-system erhållit...
Redeye raises the likelihood of approval for lecanemab from 55% to 63% and adjusts the price of leca...
Redeyes main takeaway is that Nanologica adds support (pharma companies) in Drug Development and adds prospects in the preparative (Chromato...
We believe Q2 2021 will be strong and forecast 20% y/y growth (18% organic), with 18% adjusted EBITD...
Footway Group's Q2 sales came in SEK 17m or 4% below our forecast for a growth of 32% y-o-y.
Acquires IVF diagnostics company Igenomix Pays 36x LTM EV/EBITDA Pre-announced Q2’21 – CER sales growth of 94% On Thursday 7 July, Vitrolife...
Redeye återupptar bevakningen av Starbreeze. Vår uppfattning är att bolaget har en stabil grund att ...
CapMan has guided for two new fundraising projects for 2021 targeting international investors specif...
Q2 to show strong improvements in PBLL y-o-y We now expect EO DPS of DKK 47 alongside Q2 Trading at a 22e P/E of 9.
Recurring PTP up 2% y-o-y, SEK 247m, -7% v. ABGSCe Large value uplifts following sector-wide yield s...
Ahead of CDON’s Q2 2021 results, we downgrade our GMV forecasts, reflecting muted site traffic data ...
Talenom announced today that it has acquired Spanish accounting firm Avail Services SL in Barcelona and expanded to the Spanish market.
We have looked at the Finnish accounting service market and we continue to view Talenom’s business m...
Redeye leaves a short comment following the capital injection of SEK 14,4m before transaction costs ...
